Divisadero Street Discloses 218,918-Share (0.5%) Stake in RxSight (RXST)
Divisadero Street Capital and affiliated entities, together with William Zolezzi, report beneficial ownership of 218,918 shares of RxSight common stock, representing approximately 0.5% of the class.
Rhea-AI Filing Summary
Divisadero Street Capital and affiliated entities, together with William Zolezzi, report beneficial ownership of 218,918 shares of RxSight common stock, representing approximately 0.5% of the class. The filing shows no sole voting or dispositive power and reports shared voting and dispositive power over 218,918 shares, indicating coordinated control among the reporting persons rather than individual sole authority. The report states these securities are directly owned by advisory clients of Divisadero Street Capital Management and that no advisory client holds more than 5% of the class.
The filing is submitted as a Schedule 13G/A by the investment-adviser and affiliated entities and includes a joint filing agreement and an exhibit identifying the control person.
Positive
- None.
Negative
- None.
Insights
TL;DR Small, passive 0.5% position by Divisadero Street; unlikely to affect RxSight's control or near-term valuation.
The filing discloses 218,918 shares (≈0.5%) held with shared voting and dispositive authority and 0 shares held with sole authority. Because the holdings are directly owned by advisory clients and each client is stated not to hold more than 5%, this appears to be a routine disclosure of a passive investment position rather than an activist or controlling stake. For investors, the filing signals transparency about ownership structure but does not indicate material governance influence or a shift in control.
TL;DR Joint filing shows coordinated reporting and shared power, but the sub-5% stake limits formal governance influence.
The schedule identifies multiple affiliated reporting persons and records shared voting and dispositive power over the same block of 218,918 shares. The presence of a joint filing agreement and a control-person identification exhibit is standard where related entities coordinate. Because the position is below the 5% ownership threshold and the filing expressly states the securities are held for advisory clients, the legal and governance implication is limited: disclosure is required and provided, but no material change to board-level influence is indicated.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who filed the Schedule 13G/A for RxSight (RXST)?
What exhibits accompany the Schedule 13G/A filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.